Combined inhibition of protein kinase B and enhancer of zeste homolog 2: a novel strategy to induce triple-negative breast cancer cell death
Saved in:
| Main Authors: | Xinxiao Zhu, Yongqiang Wang, Long Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Molecular Biomedicine |
| Online Access: | https://doi.org/10.1186/s43556-025-00294-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Publisher Correction: Combined inhibition of protein kinase B and enhancer of zeste homolog 2: a novel strategy to induce triple-negative breast cancer cell death
by: Xinxiao Zhu, et al.
Published: (2025-08-01) -
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs ex vivo
by: Ayako Sedohara, et al.
Published: (2025-04-01) -
NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer
by: Behrad Darvishi, et al.
Published: (2017-06-01) -
Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01) -
Metformin-Based Combination Approaches for Triple-Negative Breast Cancer
by: Zaid Sirhan, et al.
Published: (2025-04-01)